Skip to main content
Clinical Trials/NCT05108662
NCT05108662
Completed
Not Applicable

Comparison of Surgical Stress in Patients Undergoing TURP Versus HOLEP Surgery by Measuring Perioperative Systemic Inflammatory Markers

Adana City Training and Research Hospital1 site in 1 country50 target enrollmentFebruary 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prostate Hyperplasia
Sponsor
Adana City Training and Research Hospital
Enrollment
50
Locations
1
Primary Endpoint
inflamatory markers
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Aim of the study is to compare the systemic inflammatory markers and surgical stress response in patients undergoing HOLEP or TUR-P surgery.

Detailed Description

Benign prostatic hyperplasia (BPH) is the most common disease in aging men worldwide, causing significant difficulties and resulting in bladder outlet obstruction. Basically, surgical techniques in patients with BPH are transurethral resection of the prostate (TURP), holmium laser enucleation of the prostate (HOLEP), and open prostoactemy surgery. There are many studies comparing the clinical outcomes of TURP and HOLEP surgery. However, to the best of our knowledge, there has not been a study comparing the effects of these two types of surgery on inflammatory markers and stress hormones.

Registry
clinicaltrials.gov
Start Date
February 1, 2020
End Date
August 30, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
Adana City Training and Research Hospital
Responsible Party
Principal Investigator
Principal Investigator

Baris Arslan, MD

Baris Arslan, MD, Principal investigator

Adana City Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • ASA scores I-III patients
  • having benign prostatic hyperplasia
  • undergoing HOLEP or TURP surgery under general anesthesia

Exclusion Criteria

  • immune system disease,
  • diabetes mellitus,
  • malignancy other than prostate disease,
  • history of steroid use,

Outcomes

Primary Outcomes

inflamatory markers

Time Frame: Change from baseline CD4+/CD8+ at postoperative 0th and postoperative 24th hourL-6 (pg/ml) and TNF-alfa (pg/ml)

CD4+/CD8+

Stress hormone levels

Time Frame: Change from baseline adrenaline (ng/L) at postoperative 0th and postoperative 24th hour

Adrenaline (ng/L)

stress hormone levels

Time Frame: Change from baseline cortisol (microg/dl) at postoperative 0th and postoperative 24th hour

Cortisol (microg/dl)

Study Sites (1)

Loading locations...

Similar Trials